New vaccines against hepatitis B, tetanus, cancer inaugurated
In a bid to save Nigerians from deadly communicable diseases, new vaccines against hepatitis B, tetanus and pertussis have been produced and launched in the country.
The vaccine, which is a product of Biological E. Limited, in partnership with Olpharm Nigeria Limited, will centre on providing immediate solutions to the rising hepatitis B epidemic and other health challenging diseases in Nigeria and other parts of African countries.
The Assistant General Manager, Biological E. Limited, Dulam Pramodh, disclosed this during the launch of four vaccines namely, ComBe-Five vaccine against pertussis in infants, BE Td against diphtheria in adults, and Bett against tetanus infection and BEVAC against hepatitis B in Lagos at the weekend.
“Biological E. Limited has been into the manufacturing of vaccines since 1963 and has supplied vaccines to many countries. We have also been supplying to Nigeria since 2011, and have scheduled to supply in 2020. So far, we have accomplished our aim to reach our target market.
“In order to raise the awareness of the killer disease in the country, we intend to embark on a massive campaign to create awareness and educate the society of the risk and dangers of not being vaccinated,” he said
Responding to the concerns on the availability and supply rate of the vaccines in Nigeria in order to avoid scarcity, Pramodh assured that there was no cause for concern, adding that the company with innovative technology, has always ensured continuity in the production of vaccines since inception.
He said; “For over five decades now, we have ensured that our products are within reach and can be accessed at an affordable rate to satisfy our target market. So with the invention of the new technology today, we can confidently guarantee the frequent supply of all the vaccines,” he noted.
Also speaking at the event, which was attended by medical practitioners from the Lagos State University Teaching Hospital (LASUTH) and other medical professors, the company’s product development manager, Lola Adeyiga, who revealed the functions and health benefits of the vaccines in the human immune system, noting that its major function is to prevent diseases from attacking the immune system.
Meanwhile, as part of the drive forwards eliminating Lassa fever in Nigeria, a nationwide sanitisation campaign has begun in open markets to curb the prevalence of the deadly disease especially in the most affected states in the.
The sanitisation campaign initiated by Hypo Bleach in collaboration with the Nigeria Centre for Disease Control (NCDC) will have personnel of both organisations visits major open markets across 11 states in the country to enlighten market women and the entire public on the Lassa fever epidemic, as well as steps to keep their environment clean and effectively sanitised towards curbing the spread.
Nigeria has registered an upsurge in the number of Lassa fever cases since the beginning of the year, with 365 positive cases and 47 deaths reported from 23 states across the country.
According to a week five-situation report on the disease released by the Nigeria Centre for Disease Control (NCDC) on Wednesday, the number of states reporting at least a case of the disease rose to 23 from 19 in the previous week.
Speaking at the event at Oke Arin Market, Brand Manager of Hypo Bleach, Omotunde Bamigbaiye, said the need to embark on this nature of campaign became apparent as it is a common knowledge that women remain the custodians of the family and managers of house affairs, which is why catching up with them at the market square remains a strategic touchpoint to disseminate the message.
“Thursdays have been earmarked especially for environmental sanitation exercise across most major open markets in Nigeria. The idea is to have the public incorporate effective sanitisation approach into their regular cleaning, while at the same time take them through step by step processes to prevent the spread of Lassa fever both at their shops and at home,” she said.
No comments yet